1. 164: PARIS: A phase I study of pembrolizumab anti-PD-1 monoclonal antibody in combination with radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC). (January 2017) Authors: Kordbacheh, T.; Chan, C.; Bossons, A.; Franks, K.; McDonald, F.; Forster, M.; Mendes, R.; Quezada, S.; Dovedi, S.; Ralph, C.; Popat, S.; Harrington, K.; Melcher, A.; Popple, A.; Illidge, T.; Faivre-Finn, C. Journal: Lung cancer Issue: Volume 103(2017)Supplement 1 Page Start: S75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗